 | • レポートコード：MRC2Q12-08814 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：消費財 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、局所角質溶解医薬品のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 局所角質溶解医薬品のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 局所角質溶解医薬品の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 局所角質溶解医薬品のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの局所角質溶解医薬品の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の局所角質溶解医薬品の売上および2028年までの予測に焦点を当てています。 局所角質溶解医薬品のグローバル主要企業には、Allergan、Teva Branded Pharm、Padagis Us、Gordon Laboratories、Valeant、Neutrogena、Prestige、Summers、Johnson and Johnson、Bayer、Reckitt Benckiser、Unilever、Mentholatum、Blistex、Envy Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 局所角質溶解医薬品市場は、タイプとアプリケーションによって区分されます。世界の局所角質溶解医薬品市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 クリーム、乳液、ジェル 【アプリケーション別セグメント】 病院、美容院、スーパーマーケット、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 局所角質溶解医薬品製品概要 - タイプ別市場（クリーム、乳液、ジェル） - アプリケーション別市場（病院、美容院、スーパーマーケット、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の局所角質溶解医薬品販売量予測2017-2028 - 世界の局所角質溶解医薬品売上予測2017-2028 - 局所角質溶解医薬品の地域別販売量 - 局所角質溶解医薬品の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別局所角質溶解医薬品販売量 - 主要メーカー別局所角質溶解医薬品売上 - 主要メーカー別局所角質溶解医薬品価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（クリーム、乳液、ジェル） - 局所角質溶解医薬品のタイプ別販売量 - 局所角質溶解医薬品のタイプ別売上 - 局所角質溶解医薬品のタイプ別価格 ・アプリケーション別市場規模（病院、美容院、スーパーマーケット、その他） - 局所角質溶解医薬品のアプリケーション別販売量 - 局所角質溶解医薬品のアプリケーション別売上 - 局所角質溶解医薬品のアプリケーション別価格 ・北米市場 - 北米の局所角質溶解医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所角質溶解医薬品市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの局所角質溶解医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所角質溶解医薬品市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の局所角質溶解医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所角質溶解医薬品市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の局所角質溶解医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所角質溶解医薬品市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの局所角質溶解医薬品市場規模（タイプ別、アプリケーション別） - 主要国別の局所角質溶解医薬品市場規模（トルコ、サウジアラビア） ・企業情報 Allergan、Teva Branded Pharm、Padagis Us、Gordon Laboratories、Valeant、Neutrogena、Prestige、Summers、Johnson and Johnson、Bayer、Reckitt Benckiser、Unilever、Mentholatum、Blistex、Envy Medical ・産業チェーン及び販売チャネル分析 - 局所角質溶解医薬品の産業チェーン分析 - 局所角質溶解医薬品の原材料 - 局所角質溶解医薬品の生産プロセス - 局所角質溶解医薬品の販売及びマーケティング - 局所角質溶解医薬品の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 局所角質溶解医薬品の産業動向 - 局所角質溶解医薬品のマーケットドライバー - 局所角質溶解医薬品の課題 - 局所角質溶解医薬品の阻害要因 ・主な調査結果 |
Topical keratolytics are agents that are applied on the skin to soften the keratin. They loosen and assist exfoliation of the skin cells. Keratolytics also help the skin to bind moisture and is useful in treating dry skin conditions.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Topical Keratolytics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Topical Keratolytics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Topical Keratolytics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Topical Keratolytics include Allergan, Teva Branded Pharm, Padagis Us, Gordon Laboratories, Valeant, Neutrogena, Prestige, Summers and Johnson and Johnson, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Topical Keratolytics manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Topical Keratolytics market. Further, it explains the major drivers and regional dynamics of the global Topical Keratolytics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Allergan
Teva Branded Pharm
Padagis Us
Gordon Laboratories
Valeant
Neutrogena
Prestige
Summers
Johnson and Johnson
Bayer
Reckitt Benckiser
Unilever
Mentholatum
Blistex
Envy Medical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Topical Keratolytics Segment by Type
Cream
Emulsion
Gel
Topical Keratolytics Segment by Application
Hospital
Beauty Salon
Supermarket
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Topical Keratolytics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Topical Keratolytics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Topical Keratolytics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Topical Keratolytics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Topical Keratolytics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Topical Keratolytics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Topical Keratolytics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Allergan, Teva Branded Pharm, Padagis Us, Gordon Laboratories, Valeant, Neutrogena, Prestige, Summers and Johnson and Johnson, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Topical Keratolytics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Topical Keratolytics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Topical Keratolytics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Topical Keratolytics Product Introduction
1.2 Market by Type
1.2.1 Global Topical Keratolytics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cream
1.2.3 Emulsion
1.2.4 Gel
1.3 Market by Application
1.3.1 Global Topical Keratolytics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Beauty Salon
1.3.4 Supermarket
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Topical Keratolytics Sales Estimates and Forecasts 2017-2028
2.2 Global Topical Keratolytics Revenue Estimates and Forecasts 2017-2028
2.3 Global Topical Keratolytics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Topical Keratolytics Sales by Region
2.4.1 Global Topical Keratolytics Sales by Region (2017-2022)
2.4.2 Global Sales Topical Keratolytics by Region (2023-2028)
2.5 Global Topical Keratolytics Revenue by Region
2.5.1 Global Topical Keratolytics Revenue by Region (2017-2022)
2.5.2 Global Topical Keratolytics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Topical Keratolytics Sales by Manufacturers
3.1.1 Global Top Topical Keratolytics Manufacturers by Sales (2017-2022)
3.1.2 Global Topical Keratolytics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Topical Keratolytics in 2021
3.2 Global Topical Keratolytics Revenue by Manufacturers
3.2.1 Global Topical Keratolytics Revenue by Manufacturers (2017-2022)
3.2.2 Global Topical Keratolytics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Topical Keratolytics Revenue in 2021
3.3 Global Topical Keratolytics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Topical Keratolytics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Topical Keratolytics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Topical Keratolytics Sales by Type
4.1.1 Global Topical Keratolytics Historical Sales by Type (2017-2022)
4.1.2 Global Topical Keratolytics Forecasted Sales by Type (2023-2028)
4.1.3 Global Topical Keratolytics Sales Market Share by Type (2017-2028)
4.2 Global Topical Keratolytics Revenue by Type
4.2.1 Global Topical Keratolytics Historical Revenue by Type (2017-2022)
4.2.2 Global Topical Keratolytics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Topical Keratolytics Revenue Market Share by Type (2017-2028)
4.3 Global Topical Keratolytics Price by Type
4.3.1 Global Topical Keratolytics Price by Type (2017-2022)
4.3.2 Global Topical Keratolytics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Topical Keratolytics Sales by Application
5.1.1 Global Topical Keratolytics Historical Sales by Application (2017-2022)
5.1.2 Global Topical Keratolytics Forecasted Sales by Application (2023-2028)
5.1.3 Global Topical Keratolytics Sales Market Share by Application (2017-2028)
5.2 Global Topical Keratolytics Revenue by Application
5.2.1 Global Topical Keratolytics Historical Revenue by Application (2017-2022)
5.2.2 Global Topical Keratolytics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Topical Keratolytics Revenue Market Share by Application (2017-2028)
5.3 Global Topical Keratolytics Price by Application
5.3.1 Global Topical Keratolytics Price by Application (2017-2022)
5.3.2 Global Topical Keratolytics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Topical Keratolytics Market Size by Type
6.1.1 North America Topical Keratolytics Sales by Type (2017-2028)
6.1.2 North America Topical Keratolytics Revenue by Type (2017-2028)
6.2 North America Topical Keratolytics Market Size by Application
6.2.1 North America Topical Keratolytics Sales by Application (2017-2028)
6.2.2 North America Topical Keratolytics Revenue by Application (2017-2028)
6.3 North America Topical Keratolytics Market Size by Country
6.3.1 North America Topical Keratolytics Sales by Country (2017-2028)
6.3.2 North America Topical Keratolytics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Topical Keratolytics Market Size by Type
7.1.1 Europe Topical Keratolytics Sales by Type (2017-2028)
7.1.2 Europe Topical Keratolytics Revenue by Type (2017-2028)
7.2 Europe Topical Keratolytics Market Size by Application
7.2.1 Europe Topical Keratolytics Sales by Application (2017-2028)
7.2.2 Europe Topical Keratolytics Revenue by Application (2017-2028)
7.3 Europe Topical Keratolytics Market Size by Country
7.3.1 Europe Topical Keratolytics Sales by Country (2017-2028)
7.3.2 Europe Topical Keratolytics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Topical Keratolytics Market Size by Type
8.1.1 Asia Pacific Topical Keratolytics Sales by Type (2017-2028)
8.1.2 Asia Pacific Topical Keratolytics Revenue by Type (2017-2028)
8.2 Asia Pacific Topical Keratolytics Market Size by Application
8.2.1 Asia Pacific Topical Keratolytics Sales by Application (2017-2028)
8.2.2 Asia Pacific Topical Keratolytics Revenue by Application (2017-2028)
8.3 Asia Pacific Topical Keratolytics Market Size by Region
8.3.1 Asia Pacific Topical Keratolytics Sales by Region (2017-2028)
8.3.2 Asia Pacific Topical Keratolytics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Topical Keratolytics Market Size by Type
9.1.1 Latin America Topical Keratolytics Sales by Type (2017-2028)
9.1.2 Latin America Topical Keratolytics Revenue by Type (2017-2028)
9.2 Latin America Topical Keratolytics Market Size by Application
9.2.1 Latin America Topical Keratolytics Sales by Application (2017-2028)
9.2.2 Latin America Topical Keratolytics Revenue by Application (2017-2028)
9.3 Latin America Topical Keratolytics Market Size by Country
9.3.1 Latin America Topical Keratolytics Sales by Country (2017-2028)
9.3.2 Latin America Topical Keratolytics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Topical Keratolytics Market Size by Type
10.1.1 Middle East and Africa Topical Keratolytics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Topical Keratolytics Revenue by Type (2017-2028)
10.2 Middle East and Africa Topical Keratolytics Market Size by Application
10.2.1 Middle East and Africa Topical Keratolytics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Topical Keratolytics Revenue by Application (2017-2028)
10.3 Middle East and Africa Topical Keratolytics Market Size by Country
10.3.1 Middle East and Africa Topical Keratolytics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Topical Keratolytics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Teva Branded Pharm
11.2.1 Teva Branded Pharm Corporation Information
11.2.2 Teva Branded Pharm Overview
11.2.3 Teva Branded Pharm Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Branded Pharm Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Branded Pharm Recent Developments
11.3 Padagis Us
11.3.1 Padagis Us Corporation Information
11.3.2 Padagis Us Overview
11.3.3 Padagis Us Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Padagis Us Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Padagis Us Recent Developments
11.4 Gordon Laboratories
11.4.1 Gordon Laboratories Corporation Information
11.4.2 Gordon Laboratories Overview
11.4.3 Gordon Laboratories Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Gordon Laboratories Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Gordon Laboratories Recent Developments
11.5 Valeant
11.5.1 Valeant Corporation Information
11.5.2 Valeant Overview
11.5.3 Valeant Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Valeant Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Valeant Recent Developments
11.6 Neutrogena
11.6.1 Neutrogena Corporation Information
11.6.2 Neutrogena Overview
11.6.3 Neutrogena Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Neutrogena Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Neutrogena Recent Developments
11.7 Prestige
11.7.1 Prestige Corporation Information
11.7.2 Prestige Overview
11.7.3 Prestige Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Prestige Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Prestige Recent Developments
11.8 Summers
11.8.1 Summers Corporation Information
11.8.2 Summers Overview
11.8.3 Summers Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Summers Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Summers Recent Developments
11.9 Johnson and Johnson
11.9.1 Johnson and Johnson Corporation Information
11.9.2 Johnson and Johnson Overview
11.9.3 Johnson and Johnson Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson and Johnson Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson and Johnson Recent Developments
11.10 Bayer
11.10.1 Bayer Corporation Information
11.10.2 Bayer Overview
11.10.3 Bayer Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Bayer Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bayer Recent Developments
11.11 Reckitt Benckiser
11.11.1 Reckitt Benckiser Corporation Information
11.11.2 Reckitt Benckiser Overview
11.11.3 Reckitt Benckiser Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Reckitt Benckiser Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Reckitt Benckiser Recent Developments
11.12 Unilever
11.12.1 Unilever Corporation Information
11.12.2 Unilever Overview
11.12.3 Unilever Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Unilever Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Unilever Recent Developments
11.13 Mentholatum
11.13.1 Mentholatum Corporation Information
11.13.2 Mentholatum Overview
11.13.3 Mentholatum Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Mentholatum Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Mentholatum Recent Developments
11.14 Blistex
11.14.1 Blistex Corporation Information
11.14.2 Blistex Overview
11.14.3 Blistex Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Blistex Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Blistex Recent Developments
11.15 Envy Medical
11.15.1 Envy Medical Corporation Information
11.15.2 Envy Medical Overview
11.15.3 Envy Medical Topical Keratolytics Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Envy Medical Topical Keratolytics Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Envy Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Topical Keratolytics Industry Chain Analysis
12.2 Topical Keratolytics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Topical Keratolytics Production Mode & Process
12.4 Topical Keratolytics Sales and Marketing
12.4.1 Topical Keratolytics Sales Channels
12.4.2 Topical Keratolytics Distributors
12.5 Topical Keratolytics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Topical Keratolytics Industry Trends
13.2 Topical Keratolytics Market Drivers
13.3 Topical Keratolytics Market Challenges
13.4 Topical Keratolytics Market Restraints
14 Key Findings in The Global Topical Keratolytics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer